Millipore Corporation (MIL) To Acquire NovAseptic AB: Broaden Offering To Biotech And Pharmaceutical Companies; $91 Million
10/19/2005 5:09:25 PM
BILLERICA, Mass.--(BUSINESS WIRE)--July 7, 2005--
Acquisition will expand Millipore's capabilities in aseptic processing and process monitoring tools.
Millipore Corporation (NYSE:MIL) today announced that it has entered into an agreement to acquire NovAseptic AB. The all cash transaction will result in Millipore acquiring all of the shares of NovAseptic AB for approximately SEK 720 million ($91 million at current exchange rates). NovAseptic, based in Gothenburg, Sweden, provides a range of innovative solutions for aseptic processing applications in biotech and pharmaceutical manufacturing operations. NovAseptic's products include a unique disposable sampling system (NovaSeptum(R)) and a range of high-performance mixers, valves, and connectors.
Martin Madaus, Millipore's Chairman, CEO and President, noted: "NovAseptic's products and customer relationships are a strong strategic fit with Millipore's Bioprocess Division. The talented scientists and engineers at NovAseptic also enhance our already strong applications expertise in the area of aseptic processing. As part of our overall growth strategy, the acquisition of NovAseptic accelerates our plan to expand the breadth of our solutions to biotech and pharmaceutical customers, particularly in the areas of high-performance components and process monitoring tools."
comments powered by